Pages that link to "Q33393912"

The following pages link to NAP and D-SAL: neuroprotection against the beta amyloid peptide (1-42) (Q33393912):

Displaying 24 items.

• Timing of therapies for Down syndrome: the sooner, the better (Q26779297) (← links)
• Mouse models of Down syndrome as a tool to unravel the causes of mental disabilities (Q26863005) (← links)
• RGS2 expression predicts amyloid-β sensitivity, MCI and Alzheimer's disease: genome-wide transcriptomic profiling and bioinformatics data mining. (Q31134674) (← links)
• Alzheimer's disease: clinical trials and drug development (Q33349401) (← links)
• Ameliorative effect of NAP on laser-induced retinal damage (Q33810607) (← links)
• Strategies for diminishing katanin-based loss of microtubules in tauopathic neurodegenerative diseases (Q34505647) (← links)
• Alzheimer's disease and the amyloid cascade hypothesis: a critical review (Q35855587) (← links)
• Strategies to defeat ketamine-induced neonatal brain injury (Q35980939) (← links)
• Neurotrophic Peptides: Potential Drugs for Treatment of Amyotrophic Lateral Sclerosis and Alzheimer's disease (Q36940103) (← links)
• Microtubule stabilising peptides rescue tau phenotypes in-vivo (Q37464820) (← links)
• Novel strategies for the prevention of dementia from Alzheimer's disease. (Q37544750) (← links)
• d-Arginine action against neurotoxicity induced by glucocorticoids in the brain (Q37846902) (← links)
• Pharmacologists and Alzheimer disease therapy: to boldly go where no scientist has gone before. (Q37910243) (← links)
• Is it possible to improve neurodevelopmental abnormalities in Down syndrome? (Q37912174) (← links)
• Pharmacological approaches for Alzheimer's disease: neurotransmitter as drug targets. (Q38286222) (← links)
• Microtubule-Tau Interaction as a Therapeutic Target for Alzheimer's Disease (Q38713424) (← links)
• ADNP/NAP dramatically increase microtubule end-binding protein-Tau interaction: a novel avenue for protection against tauopathy (Q38766657) (← links)
• The neuroprotective peptide NAP does not directly affect polymerization or dynamics of reconstituted neural microtubules (Q39769557) (← links)
• Tau pathology: predictive diagnostics, targeted preventive and personalized medicine and application of advanced research in medical practice (Q41945501) (← links)
• A double-blind, placebo-controlled, ascending-dose, randomized study to evaluate the safety, tolerability and effects on cognition of AL-108 after 12 weeks of intranasal administration in subjects with mild cognitive impairment (Q43958437) (← links)
• D-SAL and NAP: Two Peptides Sharing a SIP Domain (Q48946832) (← links)
• NAP alpha-aminoisobutyric acid (IsoNAP). (Q50693898) (← links)
• Activity-dependent neuroprotective protein (ADNP) is an alcohol-responsive gene and negative regulator of alcohol consumption in female mice (Q90218020) (← links)
• VIP/PACAP-Based Drug Development: The ADNP/NAP-Derived Mirror Peptides SKIP and D-SKIP Exhibit Distinctive in vivo and in silico Effects (Q93013712) (← links)